Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt Countries

Background. Through its normative and public health leadership roles, the World Health Organization (WHO) plays a key role in the availability of vaccine products in low-and middle-income countries. The recent introduction of a new group A meningococcal conjugate vaccine, PsA-TT (MenAfriVac), in Afr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Dellepiane, Nora, Akanmori, Bartholomew Dicky, Gairola, Sunil, Jadhav, Suresh S., Parker, Cathy, Rodriguez, Carmen, Srivastava, Swati
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639481/
https://ncbi.nlm.nih.gov/pubmed/26553671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ491
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados